The menopause in Spain: Results of the DAMES (Decisions at MEnopause) study

被引:42
作者
Obermeyer, CM
Reher, D
Alcala, LC
Price, K
机构
[1] Harvard Univ, Dept Populat & Int Hlth, Boston, MA 02115 USA
[2] Univ Complutense Madrid, Fac Social & Polit Sci, Madrid, Spain
[3] Univ Connecticut, Storrs, CT 06269 USA
关键词
menopause; Spain; hormone therapy; decisions; alternative medications;
D O I
10.1016/j.maturitas.2005.01.011
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: To assess the symptomatology of menopause and the use of hormone therapy among women in Spain. Methods: A survey conducted on a representative sample of 300 women aged 45-55 in Madrid. The instrument included closed- and open-ended questions about demographic and socio-economic information, health and reproductive history, symptoms in past month, use of health services, life style, and therapeutic decisions. Results: Eighty-three percent of respondents report five or more symptoms. Joint pains, weight gain, mood changes and nervousness are the most frequently reported; just under half of respondents report hot flashes; 4/5 report emotional/mental symptoms. The frequencies of some symptoms vary with socio-economic status. Two-thirds of respondents have consulted physicians, and 10% are currently taking hormone therapy; the use of hormone therapy is lower among women from the lower strata. One-fifth of respondents use of nonconventional and alternative medications. Just under half of respondents find that menopause is difficult. Conclusion: Symptom reporting is relatively high, but general symptoms are more frequent than "core" menopausal symptoms. The use of hormone therapy is relatively low, but the use of alternative medicines is relatively high. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:190 / 198
页数:9
相关论文
共 26 条
[1]   Impact of the women's health initiative trial results on hormone replacement therapy [J].
Bestul, MB ;
McCollum, M ;
Hansen, LB ;
Saseen, JJ .
PHARMACOTHERAPY, 2004, 24 (04) :495-499
[2]   Patients' and clinicians' attitudes after the Women's Health Initiative study [J].
Blümel, JE ;
Castelo-Branco, C ;
Chedraui, PA ;
Binfa, L ;
Dowlani, B ;
Gómez, MS ;
Sarrá, S .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2004, 11 (01) :57-61
[3]   CLIMACTERIC AND MENOPAUSE IN 7 SOUTH-EAST ASIAN COUNTRIES [J].
BOULET, MJ ;
ODDENS, BJ ;
LEHERT, P ;
VEMER, HM ;
VISSER, A .
MATURITAS, 1994, 19 (03) :157-176
[4]  
Conde Fernando, 2002, Rev. Esp. Salud Publica, V76, P493, DOI 10.1590/s1135-57272002000500011
[5]   Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results [J].
Haas, JS ;
Kaplan, CP ;
Gerstenberger, EP ;
Kerlikowske, K .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) :184-188
[6]   National use of postmenopausal hormone therapy - Annual trends and response to recent evidence [J].
Hersh, AL ;
Stefanick, ML ;
Stafford, RS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (01) :47-53
[7]  
*I EST COM MADR, 1999, EXPL IMP RENT PERS F
[8]  
*I NAC EST, CENS POBL VIV 2001
[9]  
Joossens L, 1999, Rev Esp Salud Publica, V73, P3, DOI 10.1590/S1135-57271999000100002
[10]   MENOPAUSE RESEARCH - THE KORPILAMPI WORKSHOP [J].
KAUFERT, P ;
LOCK, M ;
MCKINLAY, S ;
BEYENNE, Y ;
COOPE, J ;
DAVIS, D ;
ELIASSON, M ;
GOGNALONSNICOLET, M ;
GOODMAN, M ;
HOLTE, A .
SOCIAL SCIENCE & MEDICINE, 1986, 22 (11) :1285-1289